Endothelial dysfunction and morphofunctional properties of erythrocytes in non-alcoholic steathohepatitis combined with chronic obstructive pulmonary disease in patients with obesity
Full Text:PDF (Українська)
Federico A, Dallio M, Masarone M, Persico M, Loguercio C. The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction. Eur Rev Med Pharmacol Sci. 2016;20(22):4731-4741. PMID: 27906428.
Fan Y, Wei F, Zhou Y, Zhang H. Association of non-alcoholic fatty liver disease with impaired endothelial function by flow-mediated dilation: A meta-analysis. Hepatol Res. 2016;46(3):165-73. doi: 10.1111/hepr.12554.
Ambrosino P, Lupoli R, Iervolino S, et al. Clinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis. Intern Emerg Med. 2017. doi: 10.1007/s11739-017-1690-0.
Gonzalez-Paredes FJ, Hernández Mesa G, Morales Arraez D, et al. Contribution of Cyclooxygenase End Products and Oxidative Stress to Intrahepatic Endothelial Dysfunction in Early Non-Alcoholic Fatty Liver Disease. PLoS One. 2016;11(5):e0156650. doi: 10.1371/journal.pone.0156650.
Polverino F, Laucho-Contreras ME, Petersen H, et al. A Pilot Study Linking Endothelial Injury in Lungs and Kidneys in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017 Jun 1;195(11):1464-1476. doi: 10.1164/rccm.201609-1765OC.
Lebed' KN. Markers of systemic inflammation in patients with chronic obstructive pulmonary disease associated with non-alcoholic steatohepatitis. Problemy ekolohichnoi ta medychnoi henetyky i klinichnoi imunolohii. 2012;3:200-204. (in Russian).
Lebed' KN. Peroxide lipid oxidation and state of the system of antioxidant protection in patients with chronic obstructive pulmonary disease combined with nonalcoholic steatohepatitis. Ukrainskyi medychnyi almanakh. 2013;16(1):138-141. (in Ukrainian).
Jung DH, Shim JY, Lee HR, Moon BS, Park BJ, Lee YJ. Relationship between non-alcoholic fatty liver disease and pulmonary function. Intern Med J. 2012 May;42(5):541-6. doi: 10.1111/j.1445-5994.2011.02644.x.
Mapel DW, Marton JP. Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPD. Int J Chron Obstruct Pulmon Dis. 2013;8:127-34. doi: 10.2147/COPD.S40123.
Peng TC, Kao TW, Wu LW, et al. Association between pulmonary function and nonalcoholic fatty liver disease in the NHANES III study. Medicine (Baltimore). 2015 May;94(21):e907. doi: 10.1097/MD.0000000000000907.
Qin L, Zhang W, Yang Z, et al. Impaired lung function is associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in middle-aged and elderly Chinese. BMC Endocr Disord. 2017 Mar 22;17(1):18. doi: 10.1186/s12902-017-0168-4.
Lefere S, Van de Velde F, Devisscher L, et al. Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease. Int J Obes (Lond). 2017;41(8):1207-1213. doi: 10.1038/ijo.2017.102.
Federico A, Dallio M, Masarone M, Persico M, Loguercio C. The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction. Eur Rev Med Pharmacol Sci. 2016;20(22):4731-41. PMID: 27906428.
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
© "Publishing House "Zaslavsky", 1997-2018